Phase 4 study data presented at the American Academy of Pain Medicine PainConnect 2026 meeting reported that more than 90% of patients undergoing aesthetic or reconstructive procedures remained opioid-free when treated with Journavx as part of multimodal pain therapy.
Johnny Franco, MD, FACS, discusses how implant removals, biologic innovation, and patient demand for long-term tissue health are accelerating a regenerative shift in body aesthetics.
A noninvasive molecular test identifies patients more likely to respond to JAK inhibitors versus Th2-targeted therapies, potentially accelerating clearance and reducing treatment switches.
Findings provide insight into the biological mechanisms of picosecond lasers for pigmentation disorders and skin aging, potentially enabling safer parameter selection and clinical application.
Plastic surgeons are calling for a ban on dermal fillers being injected into breasts, warning the procedure carries "unacceptable" risks.
